The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world risk-stratified cancer survivorship pathways.
 
Erin Elizabeth Hahn
No Relationships to Disclose
 
Aiyu Chen
No Relationships to Disclose
 
Eric C. Haupt
No Relationships to Disclose
 
Lindsay Joe Lyons
No Relationships to Disclose
 
Talar Habeshian
No Relationships to Disclose
 
Corrine E. Munoz-Plaza
No Relationships to Disclose
 
Ernest Shen
No Relationships to Disclose
 
Huong Q Nguyen
No Relationships to Disclose
 
Michael K. Gould
No Relationships to Disclose
 
Alexander Ferreira
No Relationships to Disclose
 
Canon Milani
No Relationships to Disclose
 
Seyed M Monemian
No Relationships to Disclose
 
Christy Y Lai
No Relationships to Disclose
 
Yung-Mee Park
No Relationships to Disclose
 
Steven G Steinberg
No Relationships to Disclose
 
Farah M Brasfield
No Relationships to Disclose
 
Patricia A. Ganz
Leadership - Intrinsic LifeSciences (I)
Stock and Other Ownership Interests - Abbott Laboratories; GlaxoSmithKline; Intrinsic LifeSciences (I); Johnson & Johnson; Merck; Novartis; Pfizer; Silarus Therapeutics (I); Teva; xenon pharma (I)
Consulting or Advisory Role - Akebia Therapeutics (I); Ambys Medicines (I); American Regent (I); Astellas Pharma (I); Blue Note Therapeutics; Disc Medicine (I); GlaxoSmithKline (I); Global Blood Therapeutics (I); Gossamer Bio (I); Grail; InformedDNA; Ionis Pharmaceuticals (I); Protagonist Therapeutics (I); Regeneron (I); Rockwell Medical Technologies Inc (I); Sierra Oncology (I); Vifor Pharma (I)
Research Funding - Blue Note Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - related to iron metabolism and the anemia of chronic disease (I); Up-to-Date royalties for section editor on survivorship
Travel, Accommodations, Expenses - Intrinsic LifeSciences (I)